Use of the complement inhibitor Coversin to treat HSCT-associated TMA
2017 · Blood Advances · 45 citations
https://doi.org/10.1182/bloodadvances.2016002832
Claim or correct this author profile
Claim this profile or suggest corrections to the name, affiliation, bio, photo, or paper titles. Approved changes appear as verified CitedEvidence overlays.
12
Papers
655
Citations
6
h-index
6
i10-index
Fernando Pinto is an academic researcher from Royal Hospital for Children. The author has contributed to research in topics: Hemophilia Treatment and Research & Genomics and Rare Diseases & Immunodeficiency and Autoimmune Disorders. The author has an h-index of 6, co-authored 11 publications.
https://doi.org/10.1182/bloodadvances.2016002832
https://doi.org/10.1016/j.jtha.2024.12.020
Click to start Chat